Investigative Ophthalmology & Visual Science Cover Image for Volume 63, Issue 7
June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Overexpression of membrane bound Fas ligand accelerates inflammation in response to corneal alkali burns.
Author Affiliations & Notes
  • Sean Doherty
    Ophthalmology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States
  • Wenqi Su
    Ophthalmology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States
    Ophthalmology, Tianjin Medical University General Hospital, Tianjin, China
  • Shuo Sun
    Retina, Tianjin Medical University Eye Hospital, Tianjin, China
  • Evan Bilsbury
    Ophthalmology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States
  • Emma Wood
    Ophthalmology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States
  • Haijiang Lin
    Ophthalmology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States
  • Ann Marshak-Rothstein
    Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States
  • Bo Tian
    Ophthalmology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Sean Doherty None; Wenqi Su None; Shuo Sun None; Evan Bilsbury None; Emma Wood None; Haijiang Lin None; Ann Marshak-Rothstein None; Bo Tian None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3236 – A0271. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sean Doherty, Wenqi Su, Shuo Sun, Evan Bilsbury, Emma Wood, Haijiang Lin, Ann Marshak-Rothstein, Bo Tian; Overexpression of membrane bound Fas ligand accelerates inflammation in response to corneal alkali burns.. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3236 – A0271.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The Fas/Fas ligand (FasL) system plays an integral role in the maintenance of corneal immune privilege and regulation of corneal wound healing. Previous research has shown that membrane bound FasL (mFasL) and soluble FasL (sFasL) exert opposing pro- and anti-inflammatory effects respectively in response to corneal injury. This study aims to explore the proinflammatory role of mFasL in the setting of alkali burns in mouse corneas which are sFasL deficient.

Methods : A mouse model with a deleted matrix metalloprotrease cleavage site was established to suppress the expression of sFasL, resulting in increased levels of mFasL expression systemically. To induce injury, the corneas were exposed to alkali burns. The corneas were observed for one month following injury to monitor for corneal neovascularization (CoNV), and then harvested. The collected corneas were stained for macrophage markers F4/80 and CD11b then analyzed and quantified by immunofluorescence.

Results : The mice that overexpressed mFasL showed significantly increased CoNV 14 days after alkali burn treatment compared with wild-type mice. Analysis of the harvested corneas from mFasL mice also showed an approximately 30% increase in F4/80+ and CD11b+ inflammatory cell infiltration at 1 month compared to the control group.

Conclusions : The increased CoNV and inflammatory cell infiltration observed in the corneas of mice that overexpressed mFasL suggests that mFasL plays a proinflammatory role in the cornea after injury. Considering the impact of mFasL on corneal injury and wound healing, it may serve as a potential target for therapy in corneal disease.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×